RETRACTION: Quercetin Decreases Liver Damage in Mice with Non-Alcoholic Steatohepatitis (Basic & Clinical Pharmacology & Toxicology, (2013), 112, 6, (385-391), 10.1111/bcpt.12049);Quercetin Decreases Liver Damage in Mice with Non-Alcoholic Steatohepatitis

Basic and Clinical Pharmacology and Toxicology

Volumn 112, Issue 6, 2013, Pages 385-391

  Marcolin, Éder ^a,b   Forgiarini, Luiz Felipe ^a,b   Rodrigues, Graziella ^a,b   Tieppo, Juliana ^a,b   Borghetti, Greice Stefani ^a   Bassani, Valquiria Linck ^a   Picada, Jaqueline Nascimento ^c   Marroni, Norma Possa ^a,b,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CHOLINE; HIGH DENSITY LIPOPROTEIN; METHIONINE; QUERCETIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA DAMAGE; DRUG MECHANISM; DRUG STRUCTURE; HISTOPATHOLOGY; HYPERGLYCEMIA; LIPID PEROXIDATION; LIVER INJURY; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL;

MUS;

EID: 84878146773     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.13240     Document Type: Erratum

References (60)

1. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 2012;52:59-69.
2. Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta 2011;412:1297-305.
3. Croke B, Sampson D. Nonalcoholic fatty liver disease: implications for clinical practice and health promotion. J Nurse Pract 2012;8:45-50.
4. Day C. NASH-related liver failure: one hit too many? Am J Gastroenterol 2002;97:2058-62.
5. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol Hepatol 2002;16:663-78.
6. Day CP. Mechanisms of Steatosis: Is steatosis still the first hit? EASL; Progamms and Abstracts EASL special conference - NAFLD/NASH and related metabolic diseases 2009;63-4.
7. Pessayre D, Mansouri A, Fromenty B. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2002;282:G193-9.
8. Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol 2005;42:928-40.
9. Brunt EM. Pathology of nonalcoholic steatohepatitis. Hepatol Res 2005;33:68-71.
10. Caldwell SH, Chang CY, Nakamoto RK, Krugner-Higby L. Mitochondria in nonalcoholic fatty liver disease. Clin Liver Dis 2004;8:595-617.
11. Cotrim HP, Parise ER, Oliveira CP, Leite N, Martinelli A, Galizzi J et al. Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile. Ann Hepatol 2011;10:33-7.
12. Day C. From fat to inflammation. Gastroenterology 2006;130:207-10.
13. Oliveira CP, Faintuch J, Rascovski A, Furuya CK Jr, Bastos Mdo S, Matsuda M et al. Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) - preliminary findings. Obes Surg 2005;15:502-5.
14. Chitturi S, Farrel G. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001;21:89-104.
15. Amalia PM, Possa MN, Augusto MC, Francisca LS. Quercetin prevents oxidative stress in cirrhotic rats. Dig Dis Sci 2007;52:2616-21.
16. Gonzalez-Gallego J, Sanchez-Campos S, Tunon MJ. Anti-inflammatory properties of dietary flavonoids. Nutr Hosp 2007;22:287-93.
17. Tieppo J, Cuevas MJ, Vercelino R, Tunon MJ, Marroni NP, Gonzalez-Gallego J. Quercetin administration ameliorates pulmonary complications of cirrhosis in rats. J Nutr 2009;139:1339-46.
18. Dajas F, Rivera-Megret F, Blasina F, Arredondo F, Costa G, Lafon L et al. Neuroprotection by flavonoids. Brazilian journal of medical and biological research. Braz J Med Biol Res 2002;36:1613-20.
19. Chobot V. Simultaneous detection of pro- and antioxidative effects in the variants of the deoxyribose degradation assay. J Agric Food Chem 2010;58:2088-94.
20. Chobot V. Simultaneous detection of pro- and antioxidative effects in the variants of the deoxyribose degradation assay. J Agric Food Chem 2010;58:2088-2094.
21. Singh D, Chander V, Chopra K. The effect of quercetin, a bioflavonoid on ischemia/reperfusion induced renal injury in rats. Arch Med Res 2004;35:484-94.
22. Morales AI, Vicente-Sanchez C, Sandoval JM. et al. Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties. Food Chem Toxicol 2006;44:2092-100.
23. Tokyol C, Yilmaz S, Kahraman A, Çakar H, Polat C. The effects of desferrioxamine and quercetin on liver injury induced by hepatic ischaemia-reperfusion in rats. Acta Chir Belg 2006;106:68-72.
24. Erdman J.W Jr, Balentine D, Arab L et al. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC1-4. J Nutr 2007;137:718S-37S.
25. Marcolin E, Forgiarini LF, Tieppo J, Dias AS, Freitas LA, Marroni NP. Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis. Arq Gastroenterol 2011;48:72-9.
26. Marcolin E, San-Miguel B, Vallejo D, Tieppo J, Marroni N, González-Gallego J et al. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. J Nutr 2012;142:1821-8.
27. Newbere PM, Camargo JLVD, Clark AJ. Choline deficiency, partial hepatectomy and liver tumors in rats and mice. Toxicol Pathol 1982;10:95-106.
28. Peres W, Tunon MJ, Collado PS, Herrmann S, Marroni N, Gonzalez-Gallego J. The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction. J Hepatol 2000;33:742-50.
29. Moreira AJ, Fraga C, Alonso M et al. Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats. Biochem Pharmacol 2004;68:1939-46.
30. Physiol AJ. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 2002;83:R281-3.
31. Association AVM. AVMA Guidelines on Euthanasia - Formerly Report of the AVNA. AVNA Panel on Euthanasia, 2007.
32. Brunt E, Janney C, Bisceglie AD et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74.
33. Harrison S, Neuschwander-Tetri B. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 2004;8:861-79.
34. Kleiner DE, Brunt EM, Natta MV et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21.
35. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-9.
36. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. World J Biol Chem 1972;247:3170-5.
37. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide: general properties and effect of hyperbaric oxygen. Biochem J 1973;134:707-16.
38. Tice RR, Agurell E, Anderson D et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000;235:206-21.
39. Kaefer V, Semedo JG, Silva Kahl VF. DNA damage in brain cells and behavioral deficits in mice after treatment with high doses of amantadine. J Appl Toxicol 2010;30:745-53.
40. Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006;87:1-16.
41. Larter CZ, Yeh MM. Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol 2008; 23:1635-48.
42. Rinella ME, Elias MS, Smolak RR et al. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res 2008;49:1068-76.
43. London RM, George J. Pathogenesis of NASH: animal models. Clin Liver Dis 2007;11:55-74.
44. Vance JE. Secretion of VLDL, but not HDL, by rat hepatocytes is inhibited by theethanolamine analogue N-monomethylethanolamine. J Lipid Res 1991;32:1971-82.
45. Fast DG, Vance DE. Nascent VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evidence for a novel mechanism that regulates VLDL secretion. Biochim Biophys Acta 1995;1258:159-68.
46. de Lima VM, de Oliveira CP, Sawada LY. et al. Yo jyo hen shi ko, a novel Chinese herbal, prevents nonalcoholic steatohepatitis in ob/ob mice fed a high fat or methionine-choline-deficient diet. Liver Int 2007;27:227-34.
47. Jordao AA, Zanutto ME, Domenici FA, Portari GV, Cecchi AO, Zucoloto S et al. Progression of lipid peroxidation measured as thiobarbituric acid reactive substances, damage to DNA and histopathological changes in the liver of rats subjected to a methionine-choline-deficient diet. Basic Clin Pharmacol Toxicol 2009;105:150-5.
48. Schults MA, Nagle PW, Rensen SS, Godschalk RW, Munnia A, Peluso M et al. Decreased nucleotide excision repair in steatotic livers associates with myeloperoxidase-immunoreactivity. Mutat Res 2011;735: 75-81.
49. Hartmann A, Agurell E, Beevers C. Recommendations for conducting the in vivo alkaline Comet assay. Mutagenesis 2003;18:45-51.
50. Zeisel SH, Albright CD, Shin OH, Mar MH, Salganik RI, da Costa KA. Choline deficiency selects for resistance to p53-independent apoptosis and causes tumorigenic transformation of rat hepatocytes. Carcinogenesis 1997;18:731-8.
51. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008;585:325-37.
52. Hollman PHC, Katan MB. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother 1997;51:305-10.
53. Kim GN, Jang HD. Protective mechanism of quercetin and rutin using glutathione metabolism on HO-induced oxidative stress in HepG2 cells. Ann N Y Acad Sci 2009;1171:530-7.
54. Farombi EO, Fakoya A. Free radical scavenging and antigenotoxic activities of natural phenolic compounds in dried flowers of Hibiscus sabdariffa L. Mol Nutr Food Res 2005;49:1120-8.
55. Arredondo F, Echeverry C, Abin-Carriquiry JA. et al. After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult. Free Radic Biol Med 2010;49:738-47.
56. Barcelos GR, Angeli JP, Serpeloni JM. et al. Quercetin protects human-derived liver cells against mercury-induced DNA-damage and alterations of the redox status. Mutat Res 2011;726:109-15.
57. Silva J, Herrmann SM., Peres W, Marroni NP, González-Gallego J, Erdtmann B. Evaluation of the genotoxic effect of rutin and quercetin by comet assay and micronucleus test. Food Chem Toxicol 2002;40:941-7.
58. Jovanovic SV, Steenken S, Simic MG, Hara Y. Antioxidant properties of flavonoids: reduction potentials and electron transfer reaction of flavonoid radicals. In: Rice-Evans C.A., Packer L. (eds), Flavonoids in Health and Disease. Marcel-Dekker Inc, New York, 1998;137-61.
59. Ferguson LR. Role of plant polyphenols in genomic stability. Mutat Res 2001;475:89-111.
60. Wilms LC, Hollman PC, Boots AW, Kleinjans JC. Protection by quercetin and quercetin-rich fruit juice against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes. Mutat Res 2005;582:155-62.